Azra Sehic
Pediatric Nephrology · Kingston, PANPI 1982670808
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 187 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 21.3% — the pattern of someone who eats at a lot of different presentations.
Across 187 payments — averaging $18.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$749
- Ironshore Pharmaceuticals Inc.$619
- Pfizer$564
- Kaleo, Inc.$277
- Cranial Technologies, Inc$176
- Sanofi Pasteur Inc.$153
- plus $987 from 17 others
What the payments were for
- Food & beverage$3,524100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 24 | $749 |
| Ironshore Pharmaceuticals Inc. | 29 | $619 |
| Pfizer | 31 | $564 |
| Kaleo, Inc. | 20 | $277 |
| Cranial Technologies, Inc | 11 | $176 |
| Sanofi Pasteur Inc. | 9 | $153 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $144 |
| Supernus Pharmaceuticals, Inc. | 9 | $135 |
| Merck | 7 | $111 |
| Corium, LLC | 8 | $102 |
| Collegium Pharmaceutical, Inc. | 6 | $92 |
| Aytu Biopharma, Inc. | 4 | $61 |
| Genentech USA, Inc. | 4 | $60 |
| Organon | 3 | $45 |
| AstraZeneca | 2 | $38 |
| Seqirus USA Inc | 1 | $36 |
| Biofire Diagnostics, LLC | 1 | $36 |
| Neos Therapeutics, LP | 2 | $30 |
| Shire North American Group Inc | 2 | $27 |
| Novo Nordisk | 1 | $21 |
| Kowa Pharmaceuticals America, Inc. | 1 | $18 |
| Ultragenyx Pharmaceutical Inc. | 1 | $16 |
| Biomarin Pharmaceutical Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,524 in reported general payments places this provider in the 70th percentile of 32 pediatric nephrology providers in Pennsylvania.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fluvoxamine Maleate | 13 | $165 |
Paid to pharmacies, not to this prescriber.
Other pediatric nephrology in Kingston
- German Lozano GuzmanPhiladelphia$76K
- Brenda CooperstoneBryn Mawr$39K
- Christine SethnaPhiladelphia$17K
- Sandra AmaralPhiladelphia$14K
- Susan FurthPhiladelphia$13K
- Carlton BatesPittsburgh$6K
- Samina MuneeruddinPhiladelphia$5K
- Anil MongiaPhiladelphia$4K
- Kevin MeyersPhiladelphia$4K
- Christopher LarosaPhiladelphia$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.